17-19360357-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP5
The ENST00000261499.11(B9D1):āc.95A>Gā(p.Tyr32Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000186 in 1,613,802 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. Y32Y) has been classified as Likely benign.
Frequency
Genomes: š 0.000020 ( 0 hom., cov: 32)
Exomes š: 0.000018 ( 0 hom. )
Consequence
B9D1
ENST00000261499.11 missense
ENST00000261499.11 missense
Scores
6
3
4
Clinical Significance
Conservation
PhyloP100: 4.23
Genes affected
B9D1 (HGNC:24123): (B9 domain containing 1) This gene encodes a B9 domain-containing protein, one of several that are involved in ciliogenesis. Alterations in expression of this gene have been found in a family with Meckel syndrome. Meckel syndrome has been associated with at least six different genes. This gene is located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Mar 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PM1
In a chain B9 domain-containing protein 1 (size 203) in uniprot entity B9D1_HUMAN there are 17 pathogenic changes around while only 6 benign (74%) in ENST00000261499.11
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-19360357-T-C is Pathogenic according to our data. Variant chr17-19360357-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 217555.We mark this variant Likely_pathogenic, oryginal submissions are: {Pathogenic=1, Uncertain_significance=2}. Variant chr17-19360357-T-C is described in Lovd as [Pathogenic]. Variant chr17-19360357-T-C is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
B9D1 | NM_015681.6 | c.95A>G | p.Tyr32Cys | missense_variant | 2/7 | ENST00000261499.11 | NP_056496.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
B9D1 | ENST00000261499.11 | c.95A>G | p.Tyr32Cys | missense_variant | 2/7 | 1 | NM_015681.6 | ENSP00000261499 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152198Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
152198
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250662Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135694
GnomAD3 exomes
AF:
AC:
3
AN:
250662
Hom.:
AF XY:
AC XY:
1
AN XY:
135694
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461604Hom.: 0 Cov.: 31 AF XY: 0.0000179 AC XY: 13AN XY: 727082
GnomAD4 exome
AF:
AC:
27
AN:
1461604
Hom.:
Cov.:
31
AF XY:
AC XY:
13
AN XY:
727082
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74354
GnomAD4 genome
AF:
AC:
3
AN:
152198
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74354
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Joubert syndrome 27 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 23, 2016 | - - |
Familial aplasia of the vermis Pathogenic:1
Pathogenic, criteria provided, single submitter | research | UW Hindbrain Malformation Research Program, University of Washington | Feb 23, 2015 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 09, 2024 | Variant summary: B9D1 c.95A>G (p.Tyr32Cys) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 250662 control chromosomes. c.95A>G has been reported in the literature in individuals affected with Joubert Syndrome And Related Disorders (e.g. Romani_2014, Bachmann-Gagescu_2015). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 24886560, 26092869, 30055837). ClinVar contains an entry for this variant (Variation ID: 217555). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. - |
B9D1-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 19, 2018 | The B9D1 c.95A>G (p.Tyr32Cys) variant has been reported in a compound heterozygous state in two unrelated patients with Joubert syndrome (Romani et al. 2014; Bachmann-Gagescu et al. 2015). One compound heterozygote was described as being clinically diagnosed with "pure" Joubert syndrome and was 7 years old at the time of variant identification (Romani et al. 2014). Although the variant has not been specifically described in fetuses or liveborns with Meckel syndrome to date, a possible association with Meckel syndrome cannot be ruled out. Control data are unavailable for this variant, which is reported at a frequency of 0.00003 in the European (non-Finnish) population of the Genome Aggregation Database. Based on the evidence, the p.Tyr32Cys variant is classified as a variant of unknown significance but suspicious for pathogenicity for B9D1-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;.;.;.;.;.
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D;D;D;D;D
MutationTaster
Benign
D;D;D;D;D;N;N
PrimateAI
Benign
T
Sift4G
Pathogenic
D;D;.;.;.;.
Vest4
MVP
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at